Infectious Disease
Cryptococcus recombination event may underlie Vancouver Island outbreak
Published in Medical Letter on the CDC and FDA, December 14th, 2003
According to a study from the United States, C. neoformans "is a human fungal pathogen that exists as three distinct varieties or sibling species: the predominantly opportunistic pathogens C. neoformans var. neoformans (serotype D) and C. neoformans var. grubii (serotype A) and the primary pathogen C. neoformans var. gattii (serotypes B and C)."
"While serotypes A and D are cosmopolitan, serotypes B and C are typically restricted to tropical regions," noted J.A. Fraser and coauthors at Duke University....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Breast Cancer
Mechanisms of Taxol resistance related to microtubules reviewed - Cancer Therapy
IL-4-Pseudomonas exotoxin protein used for malignant glioma therapy - Dengue Fever
Dengue 2 PDK-53 virus used as chimeric carrier for dengue vaccine - Tuberculosis
CD4+ T cells mediate IFN-gamma-independent control of M. tuberculosis - AIDS Epidemiology
Fewer AIDS babies born in U.S. but worldwide transmissions remain epidemic - AIDS Testing
VScan maker receives IRB approval for live testing - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
